Presentation of the SACHA project at the ASCO Congress
June 2022 - oral communication
Presentations and Publications
SACHA Scientific Presentations
Presentation at the ACCELERATE meeting
February 2023
Presentation of the Regorafenib cohort at the CTOS Congress 2023
Presentation of the SACHA-ANSM collaboration experience at the ASCO Congress
June 2023 - poster
Presentation of the Trametinib/Dabrafenib cohorts at the ESMO Congress
May 2024 - poster
Presentation of the SACHAxLaro (larotrectinib) cohort at the ASCO Congress
June 2024 - poster
Presentation of the chemo-immuno cohort (Dinutuximab beta) at the ANR Congress
May 2025 - poster
Presentation of the SACHA-ANSM collaboration experience (updated data) at the CNRC
October 2025 - poster
Presentation of the SACHA International project at the SIOP Congress
October 2025 - poster
Talk about consideration of SACHA in drug access market. RWE 360 Congress
November 2025 - round table
SACHA Associated Publications
Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study
Berlanga P, Ndounga-Diakou LA, Aerts I, Corradini N, Ducassou S, Strullu M, et al.
JAMA Network Open.
2023;6(7):e2321568. doi:10.1001/jamanetworkopen.2023.21568
Chemo-immunotherapy with Dinutuximab Beta in Patients with Progressive High-Risk Neuroblastoma: Does Chemotherapy Backbone Matter?
Raiser P, Schleiermacher G, Gambart M, Dumont B, Defachelles AS, Thebaud E, et al.
European Journal of Cancer. 2024.
Article S0959-8049(24)00157-6. doi:10.xxxx/ejcancer.S0959-8049(24)00157-6 Bobin et al., Clin Cancer Res 2024
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
Bobin C, Iddir Y, Butterworth C, Masliah-Planchon J, Saint-Charles A, Bellini A, et al.
Clinical Cancer Research.
2024 Aug 1;30(15):3298-3315. doi:10.1158/1078-0432.CCR-23-0753
Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France Experience.
Berlanga P, Aerts I, Corradini N, Ndounga-Diakou LA, Entz-Werle N, Ducassou S, André N, Sevrin F, Chastagner P, Puiseux C, Cleirec M, Plantaz D, De Carli E, Gambart M, Khanfar C, Thouvenin S, Petit A, Klein S, Briandet C, Millot F, Pluchart C, Reguerre Y, Schneider P, Serre J, Halfon-Domènech C, Carausu L, Piguet C, Saumet L, Benadiba J, Abbou S, Laghouati S, Geoerger B, Vassal G
Pediatric Blood & Cancer.
2025 Feb 1; 72(2):e31449. doi:10.1002/pbc.31449
Chemo-Immunotherapy Rescue for High-Risk Neuroblastoma Patients With Progressive Disease Before High-Dose Chemotherapy: Real-World Data From the SACHA-France Study.
Pasqualini C, Proust S, Schleiermacher G, Gambart M, Jannier S, Petit A, Dupraz C, Thebaud E, Reguerre Y, Ndounga-Diakou LA, Laghouat S, Defachelles AS, Berlanga P.
Pediatric Blood & Cancer.
2025 Dec;72(12):e32080. doi: 10.1002/pbc.32080. Epub 2025 Oct 3. PMID: 41044876